pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·2h ago·1 min read
save

Grindr launches telehealth service offering erectile dysfunction and weight loss prescriptions

Oct 8, 2026·read at Endpoints ↗Neutral

Grindr has moved beyond its dating platform by introducing a telehealth service that connects users with clinicians for virtual consultations.

The offering enables users to receive prescriptions for erectile dysfunction and weight‑loss medications after an online appointment.

Analysts see the initiative as part of a growing trend of digital platforms entering the pharmaceutical space, though the company says it is still assessing early results.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Grindr's big bet on telehealth”

read at Endpoints ↗
78 words · retrieved 50m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Obesity2

related stories

  • Apr 30Updated: Early sales of Lilly’s obesity pill appear to trail Novo’sEndpoints
  • Apr 30STAT+: New obesity tool aims to predict risk of 18 serious complicationsSTAT
  • Apr 29STAT+: A patent win for Pfizer and BridgeBioSTAT
  • Apr 28STAT+: FDA launches effort to speed up clinical trials, using AISTAT
  • Apr 28Fauci adviser David Morens indicted on charges of concealing emails, avoiding records requestsSTAT